Boosting Demand Of Nanomedicine Market Due To Rising Level Of Government Participation In R&D Funding Till 2025
The
global nanomedicine market is anticipated to reach USD
350.8 billion by 2025, according to a new report by Grand View Research, Inc.
Development of novel nanotechnology-based drugs and therapies is driven by the
need to develop therapies that have fewer side effects and that are more
cost-effective than traditional therapies, in particular for cancer.
Application
of nanotechnology-based contrast reagents for diagnosis and monitoring of the
effects of drugs on an unprecedented short timescale is also attributive drive
growth in the coming years. Additionally, demand for biodegradable implants
with longer lifetimes that enable tissue restoration is anticipated to
influence demand.
U.S. nanomedicine market by products, 2013 - 2025 (USD Billion) |
As
per the WHO factsheet, cancer is found to be one of the major causes of
mortality and morbidity worldwide, with approximately 14 million new cases in
2012 and 8.2 million cancer-related deaths. Thus, demand for nanomedicine in
order to curb such high incidence rate is expected to boost market progress
during the forecast period.
Solutions
such as nanoformulations with triggered release for tailor-made
pharmacokinetics, nanoparticles for local control of tumor in combination with
radiotherapy, and functionalized nanoparticles for targeted in-vivo activation
of stem cell production are anticipated to drive R&D, consequently
resulting in revenue generation in the coming years.
Biopharmaceutical
and medical devices companies are actively engaged in development of novel
products as demonstrated by the increasingly growing partnerships between
leading enterprises and nanomedicine startups. For instance, in November 2015,
Ablynx and Novo Nordisk signed a global collaboration and a licensing agreement
for development and discovery of innovative drugs with multi-specific
nanobodies. This strategic partnership is anticipated to rise the net annual
sales of the products uplifting the market growth.
However,
in contrary with the applications of nanotechnology, the entire process of lab
to market approval is a tedious and expensive one with stringent regulatory
evaluation involved thereby leading investors to remain hesitant for
investments.
Browse full
research report on Nanomedicine Market: www.grandviewresearch.com/industry-analysis/nanomedicine-market
Further
key findings from the report suggest:
- Therapeutics accounted for the largest share of
market revenue in 2016 owing to presence of nanoemulsions,
nanoformulations, or nanodevices
- These devices possess the ability to cross
biological barriers. Moreover, presence of drugs such as Doxil, Abraxane,
and Emend is attributive for higher revenue generation
- Presence of substantial number of products
manufactured through the use of microbial sources can be attributed for
the largest share
- In-vitro diagnostics is
expected to witness lucrative progress as a result of R&D carried out
in this segment
- Introduction of nano-enabled biomarkers,
vectors and contrast agents with high-specificity and sensitivity are
attributive for projected progress
- Clinical cardiology is expected to witness the
fastest growth through to 2025 owing to development in
nano-functionalization and modification of surfaces for increased
biocompatibility of implants in treatment of late thrombosis
- Moreover, an abundance of research publications
and patent filings from European region with a share of about 25% in
nanomedicine-related publications is supportive for revenue generation
from European economies
- Asia Pacific is estimated to witness the
fastest growth over the forecast period
- Factors responsible include government and
regulatory authorities that have implemented a framework to encourage
R&D collaborations and framework extension.
- Key players operating in this industry include
Pfizer Inc., Ablynx NV, Nanotherapeutics Inc., Nanoviricides Inc., Abraxis
Inc., Arrowhead Research Inc., Celgene Corporation, Bio-Gate AG, and Merck
- Active expansion strategies are undertaken by a
number of the major market entities in order to strengthen their position
- North America dominated the industry in 2016,
accounting for a 42% of total revenue
- Presence of key participants operating in the
region are involved in collaborative activities are attributive for the
largest share of North America in sector revenue
Browse more
reports of this category by Grand View Research: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the nanomedicine market on the basis of
product, application, nanomolecule type, and region:
Nanomedicine
Product Outlook (Revenue, USD Billion; 2013 - 2025)
- Therapeutics
- Regenerative
medicine
- In-vitro
diagnostics
- In-vivo
diagnostics
- Vaccines
Nanomedicine
Application Outlook (Revenue, USD Billion; 2013 - 2025)
- Clinical
Oncology
- Infectious
diseases
- Clinical
Cardiology
- Orthopedics
- Others
Nanomedicine
Nanomolecule Type Outlook (Revenue, USD Billion; 2013 - 2025)
- Nanoparticles
- Metal
& Metal Oxide Nanoparticles
- By
Type
- Gold
Nanoparticles
- Silver
Nanoparticles
- Iron
Oxide Nanoparticles
- Alumina
Nanoparticles
- Gadolinium
Oxide Nanoparticles
- Others
- By
Application
- In-vivo Imaging
- Targeted
Drug Delivery
- Proton
Therapy
- In-vitro
assays
- Cell
& Phantom Imaging
- Liposomes
- Polymers
& polymer drug conjugates
- Hydrogel
nanoparticles
- Dendrimers
- Inorganic
nanoparticles
- Nanoshells
- Nanotubes
- Nanodevices
Nanomedicine
Regional Outlook (Revenue, USD Billion; 2013 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle
East and Africa (MEA)
- South
Africa
Access
Press Release By Grand View Research: www.grandviewresearch.com/press-release/global-nanomedicine-market
About Grand
View Research:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research
reports, and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
Comments
Post a Comment